Table 1.

CGH Changes in RMS-E and RMS-A.

Patient No.	CGH Changes
E1	+2; +3p24; +5; +8q24-qter; +11; +12; +20
E2	+2p22-pter; +3p; -4q; +7; +8q22-qter; -9; -10; -19
E3	+1p31; +8q24; +10q25
E4†	+2p; +7; +8q; +11q14-qter; +12; +14q23-qter; +18q12-21;
E5	+1; +2p; +3q24-qter; +5q23-qter; +7; +8; +9q22-qter; +11; +12q14-21*; +13; +19; +20
E6	+2; +5; +8; +13q; +14q21; -17p; +17q; -21q
E7†	+1q; +2; +3q24-qter; +5; +7; +8; +11p15; +12; +20
E8†	+5q23-32; +6q; +8q; -19
E9	+2; +6; +7; +8; +11; +13q14-qter; +14q22-qter; +18q21-22; +19; +20
E10	+2q; +6; +7; +11q; +12; +14q24-qter
A1†	+1q31; +2q; +4p; +5p; +11p15; +11q22-qter; +12q13-21*; +13q22-qter; +14q31-32
A2	+1p22-31; +2; +12q13-21*;
A3	+2p23-pter*; +5p; +9p21-23; +11p
A4	+1; +3q26-qter; +6q21; +7; +8; -9; +11; +12; -13; +15q22-qter; +17q22-qter*; +21
A5	+2p23-pter*; +9p21-23*; +11p15
A6	+2p23-pter*; +11; +12; +20
A7	+2p22-24*; +18q11-21
A8	+2p23-24*; +3p22-pter; +6p22-pter; +12q13-21; +13q21-qter; +20
A9	+2; +4; +5; +8; +11p; +12q13-21; +13q; +17; +20
A10	+1q; +13q14
A11	+1p36; +14q32

^*Denotes amplification.

NOTE. All analyses carried out before treatment except those indicated by ^†.